Food allergy immunology
True food allergy (IgE-mediated) follows a two-phase mechanism:
- Sensitisation phase:On first exposure, a food antigen (peanut Ara h 2, wheat gliadins, milk caseins) crosses gut mucosa and is processed by dendritic cells in Peyer’s patches and gut-associated lymphoid tissue (GALT). Th2-skewed dendritic cells drive naïve T cells to a Th2 phenotype, which instructs B cells to class-switch to IgE production.
- Effector phase:On re-exposure, food antigen cross-links IgE bound to high-affinity FcεRI receptors on mast cells (gut) and basophils (blood) — triggering rapid degranulation: histamine, tryptase, leukotrienes (LTC4, LTD4), and prostaglandins. This causes urticaria, angioedema, GI cramping, vomiting, and in systemic reactions, anaphylaxis.
- Th2 dominance:Atopic individuals have elevated IL-4, IL-5, IL-13, and reduced IFN-γ and IL-10. IL-4 and IL-13 drive IgE class switching; IL-5 drives eosinophil survival and recruitment.
Food intolerance (lactose, fructose, FODMAPs) is mechanistically separate — enzyme deficiency or osmotic GI effects, not immune IgE activation. Spirulina’s relevant mechanisms differ for each category.
What spirulina cannot do
This must be stated clearly:
- Spirulina does not prevent or treat anaphylaxis.Anyone with diagnosed anaphylaxis risk must carry epinephrine auto-injector (adrenaline pen) and avoid the trigger food. No supplement addresses IgE sensitisation once established.
- Spirulina does not desensitise existing IgE to specific food antigens — oral immunotherapy (OIT) under specialist supervision is the only evidence-based approach to altering established sensitisation.
- Spirulina protein itself can be an allergen in sensitised individuals — rare but documented; spirulina allergy has been reported in people with existing algae sensitivities.
GLA and eicosanoid rebalancing
Spirulina contains gamma-linolenic acid (GLA) at 0.5–1.5 g per 10 g — a proportion of total fatty acids that translates to practical amounts at 5–10 g/day. GLA has mechanistic relevance to allergic inflammation:
- GLA converts to dihomo-gamma-linolenic acid (DGLA) via Δ6-elongase. DGLA competes with arachidonic acid (AA) for COX and LOX enzymes — reducing synthesis of pro-inflammatory prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) while producing the less inflammatory prostaglandin E1 (PGE1).
- LTC4 and LTD4 (mast cell products) are the principal mediators of late-phase allergic responses — bronchoconstriction, mucosal oedema, and prolonged GI cramping. Leukotriene synthesis depends on 5-LOX using AA as substrate; DGLA is a poor substrate for 5-LOX.
- This mechanism is shared with evening primrose oil and borage oil at higher GLA doses — spirulina delivers GLA in a whole-food matrix alongside protein, iron, and phycocyanin.
Th1/Th2 immune modulation
Spirulina extracts, particularly phycocyanin and polysaccharides, shift immune responses toward Th1 in animal and in vitro models:
- NK cell activation increases IFN-γ output — which counter-regulates Th2 responses via IL-12 pathway signalling. IFN-γ directly suppresses IL-4-driven IgE class switching in B cells.
- Phycocyanin reduces IL-4 and IL-5 in sensitised animal models — the cytokines most responsible for IgE upregulation and eosinophil recruitment in atopic disease.
- One small human RCT (2005, Cingi et al.) in allergic rhinitis showed spirulina reduced IL-4 and improved symptom scores vs placebo — this is rhinitis, not food allergy, but the Th2-modulating mechanism is shared.
Gut mucosal relevance
The gut epithelial barrier and mucosal immune environment are central to food allergy:
- Increased intestinal permeability (“leaky gut”) allows larger antigen fragments to cross the epithelium — increasing sensitisation risk. Spirulina polysaccharides support tight junction protein expression (zonulin pathway) in animal models.
- Regulatory T cells (Tregs) in the gut suppress excessive allergic responses to food antigens — butyrate produced from spirulina polysaccharide fermentation by Bifidobacterium promotes Treg differentiation.
- This is a plausible mechanism for primary prevention (in high-risk infants with atopic family history) but there are no clinical trials in food allergy populations.
Food intolerance vs food allergy
Spirulina has separate relevance for food intolerance:
- Lactose intolerance: spirulina is dairy-free and provides calcium (120–170 mg/10 g) — a nutritionally relevant alternative for those avoiding dairy
- Wheat/gluten intolerance (non-coeliac): spirulina is gluten-free (verify cross-contamination with manufacturer for coeliac disease — certified gluten-free batches required)
- FODMAPs: spirulina is low-FODMAP; the polysaccharides are primarily resistant starch rather than fermentable oligosaccharides
Practical guidance
- Never use spirulina to “replace” allergy management — food allergy avoidance, adrenaline auto-injector, and specialist allergy review are irreplaceable
- Start with a very small amount (0.5 g) to rule out spirulina allergy before taking regular doses — especially if you have existing shellfish or algae sensitivities
- GLA from spirulina may contribute to the eicosanoid balance supporting reduction of late-phase inflammatory responses — 5–10 g/day provides 0.25–1.5 g GLA
- For children with atopic disease (eczema, asthma, food allergy), discuss with allergist or paediatric immunologist before introducing spirulina — NK cell stimulation is generally appropriate but case-specific review is warranted